Search results
Singer Cher Agrees to 'Pause' Fight to Place Troubled Son Elijah Allman Under Conservatorship After...
RadarOnline.com· 9 hours agoSinger Cher and her son Elijah Blue Allman have agreed to pump the brakes on their nasty court battle — only weeks after he asked a court to shut down his famous mother from obtaining his medical ...
Earnings call: Argenx reports robust Q1 growth with VYVGART expansion By Investing.com
Investing.com· 4 days agoArgenx SE (ARGX) has announced its first-quarter financial results, showcasing a strong performance...
14 Celebrity Couples Who Secretly Eloped: From Malcolm McRae and Anya Taylor-Joy to Ashton Kutcher...
RadarOnline.com· 3 days agoYears after reconciling, Ashton Kutcher and Mila Kunis tied the knot in a private ceremony in Oak...
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
GuruFocus.com via Yahoo Finance· 7 days agoDiscover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.
argenx (NASDAQ:ARGX) Posts Earnings Results, Misses Expectations By $0.33 EPS
ETF DAILY NEWS· 4 days agoargenx (NASDAQ:ARGX – Get Free Report) released its earnings results on Thursday. The company reported ($1.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.71) by ($0.33 ...
argenx Reports First Quarter 2024 Financial Results and Provides Business Update - argenx...
Benzinga· 6 days ago$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcr
Guru Focus· 7 days agoTotal Revenue: $172.3 million for Q1 2024, up from $44.8 million in Q1 2023.SYFOVRE Revenue: $137.5 million in net sales, a 20% increase from Q4.EMPAVELI Reven
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days ago$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PFS) in second quarter 2024 Management to host conference